Legal Opinion
In Re Bextra & Celebrex Marketing Sales Practices & Product Liability Litigation
District Court, N.D. California
Decided November 19, 2007No. 5:05-cv-01699PublishedCited by 29 opinions
1Opinion of the Court
MEMORANDUM AND ORDER RE: MOTIONS TO EXCLUDE EXPERT TESTIMONY
CHARLES R. BREYER, District Judge.
In this Multi-District Litigation (“MDL”) proceeding, over 3000 plaintiffs allege that they or their loved ones suffered a heart attack, stroke or other adverse cardiovascular event as a result of taking Celebrex, a pain medication manufactured by defendant Pfizer, Inc. (“Pfizer”). Pfizer has moved to exclude any expert testimony to the effect that Cele-brex is capable of causing a heart attack or stroke when ingested at 200 milligrams a day or 400 milligrams a day. Plaintiffs have also moved to…
2Cases cited9 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Walter Mixon Allen, Jr., Mattie Gayle Allen, Barry Lane Allen v. Pennsylvania Engineering Corp., American Sterilizer CompanyCourt of Appeals for the Fifth Circuit · 1996
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Court of Appeals for the Ninth Circuit · 1995
4 more not listed; retrieve them via the Exa API.
3Cited by29 opinions
- Betz v. Pneumo Abex LLCSupreme Court of Pennsylvania · 2012
- Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.Court of Appeals for the Fourth Circuit · 2018
- Deutsch Ex Rel. Estate of Deutsch v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2011
- King v. Burlington Northern Santa Fe Ry. Co.Nebraska Supreme Court · 2009
- In Re Neurontin Marketing, Sales Practices, & Products Liability LitigationDistrict Court, D. Massachusetts · 2009
24 more not listed; retrieve them via the Exa API.